• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    UnitedHealth Group Reports Second Quarter 2024 Results

    7/16/24 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    • Revenues of $98.9 Billion Grew Nearly $6 Billion Year Over Year, Led by Optum
    • Consumers Served by UnitedHealthcare's Commercial Domestic Offerings Grew 2.3 Million Year to Date
    • Cash Flows from Operations were $6.7 Billion or 1.5x Net Income
    • Second Quarter Earnings of $4.54 Per Share Reflect Classification of Remaining South American Operations as Held for Sale and Cyberattack Impacts
    • Adjusted Earnings of $6.80 Per Share Include $0.28 in Business Disruption Impacts; Exclude South American and Direct Response Costs

    UnitedHealth Group (NYSE:UNH) reported second quarter 2024 results reflecting broad-based growth at Optum and UnitedHealthcare.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716029443/en/

    UnitedHealth Group corporate headquarters (Photo: Business Wire)

    UnitedHealth Group corporate headquarters (Photo: Business Wire)

    "The diversified, durable growth across UnitedHealth Group stems from our colleagues' commitment to ensuring high-quality, affordable care is available to the people we serve, and positions us well for the near and long-term," said Andrew Witty, chief executive officer of UnitedHealth Group.

    The company updated its full year 2024 net earnings outlook to $15.95 to $16.40 per share to reflect the classification to held for sale of its remaining South America operations and the estimated Change Healthcare cyberattack impacts. The company completed the sale of its larger Brazilian operations in the first quarter of 2024.

    The company affirmed the adjusted net earnings outlook of $27.50 to $28.00 per share established at its November 2023 Investor Conference. The consistent outlook absorbs an estimated $0.60 to $0.70 per share of business disruption impacts for the affected Change Healthcare services, which has increased $0.30 per share since the initial estimate was provided last quarter.

    Cyberattack Update

    The company has restored the majority of the affected Change Healthcare services while continuing to provide financial support to the remaining health care providers in need. To date, the company has provided over $9 billion in advance funding and interest-free loans to support care providers.

    Total cyberattack impacts in the second quarter were $0.92 per share. This included $0.64 per share to support direct response efforts such as the Change Healthcare clearinghouse platform restoration and increased medical care expenditures. Additionally, Change Healthcare business disruption impacts, reflecting lost revenue and the costs of maintaining full readiness of the affected Change Healthcare services, were $0.28 per share in the second quarter.

    The company currently estimates the total full year 2024 impact at $1.90 to $2.05 per share. Within this, direct response costs are estimated at $1.30 to $1.35, an increase of $0.40 to $0.45 from the initial estimate. The change is due to the company's care provider financial support initiatives and consumer notification costs. Business disruption impacts are estimated at $0.60 to $0.70 per share.

    South America Update

    Having completed the sale of its Brazilian business, the company intends to sell its remaining South American operations. Total South American impacts in the quarter were $1.28 per share, the majority of which is non-cash and is due to the cumulative impact of foreign currency losses.

    Quarterly Financial Performance

     

    Three Months Ended

     

     

     

    June 30,

    2024

    June 30,

    2024 (Adj)

    June 30,

    2023

    December 31,

    2023

     

     

    Revenues

    $98.9 billion

     

    $99.1 billion

    $92.9 billion

    $94.4 billion

    Earnings from Operations

    $ 7.9 billion

    $ 8.7 billion

    $ 8.1 billion

    $ 7.7 billion

    Net Margin

    4.3%

    6.0%

    5.9%

    5.8%

    • Second quarter 2024 revenues grew nearly $6 billion to $98.9 billion, led by strong expansion in people served domestically at Optum and UnitedHealthcare. Second quarter earnings from operations were $7.9 billion, including $1.1 billion in unfavorable cyberattack effects. Adjusted earnings from operations of $8.7 billion include the Change Healthcare business disruption impacts and exclude the cyberattack direct response and South American impacts.
    • The second quarter 2024 reported medical care ratio of 85.1% included 65 basis points of impacts due to accommodations to support care providers (40 basis points) and South American actions (25 basis points). The increase from the prior year's 83.2% was also due to the previously noted revenue effects of CMS's Medicare funding reductions, medical reserve development effects, and business and member mix. The company did not reflect any favorable earnings impacting medical reserve development in the quarter.
    • Days claims payable of 45.2 compared to 47.1 in the first quarter of 2024 and 48.2 in the second quarter of 2023. Within this, the return to more normal claims submission patterns from care providers and, to a lesser extent, the impact of the South American actions, decreased days claims payable from the first quarter. The acceleration of claims payments to care providers and South American actions decreased days claims payable from the prior year.
    • The second quarter of 2024 operating cost ratio of 13.3% compared to 14.9% in 2023, reflecting continued strong operating cost efficiency.
    • Cash flows from operations from the second quarter of 2024 were $6.7 billion, or 1.5 times net income. In June the company increased its annual dividend rate by 12%, the 15th consecutive year of double-digit increases. During the quarter, the company prioritized financial resources to support care providers disrupted by the cyberattack.

    UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by improving health and wellness, enhancing the quality of care received, simplifying the health care experience, and reducing the total cost of care.

    Quarterly Financial Performance

     

    Three Months Ended

     

     

    June 30,

    2024

    June 30,

    2024 (Adj)

    June 30,

    2023

    December 31,

    2023

     

     

    Revenues

    $73.9 billion

     

    $74.1 billion

    $70.2 billion

    $70.8 billion

    Earnings from Operations

    $ 4.0 billion

    $ 4.4 billion

    $ 4.4 billion

    $ 3.1 billion

    Operating Margin

    5.4%

    5.9%

    6.2%

    4.4%

    • UnitedHealthcare second quarter revenues of $73.9 billion increased nearly $4 billion over the prior year, reflecting growth in the number of people served domestically. Operating earnings were $4.0 billion and adjusted operating earnings were $4.4 billion.
    • Year to date, the number of consumers served domestically with the company's commercial offerings grew by 2.3 million to 29.6 million as UnitedHealthcare's innovative and consumer focused product portfolio continues to resonate with customers.
    • The total number of people served by the company's offerings for seniors and people with complex needs grew to 9.4 million. UnitedHealthcare offerings feature product designs tailored to meet the specific needs of people who have limited economic resources and who are often underserved.
    • Total people served by the company's state-based community offerings moderated to 7.4 million, with the year-over-year change due to the state-driven Medicaid eligibility redetermination process. The UnitedHealthcare team is continuing its comprehensive outreach to help families maintain, reinstate or find other affordable coverage.

    The Optum health services businesses serve the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, analytics and technology to yield clinical insights, Optum helps improve overall health system performance by optimizing care quality, reducing care costs and improving the consumer experience.

    Quarterly Financial Performance

     

    Three Months Ended

     

     

    June 30,

    2024

    June 30,

    2024 (Adj)

    June 30,

    2023

    December 31,

    2023

     

     

    Revenues

    $62.9 billion

     

    $62.9 billion

    $56.3 billion

    $59.5 billion

     

    Earnings from Operations

    $ 3.9 billion

    $ 4.3 billion

    $ 3.7 billion

    $ 4.6 billion

     

    Operating Margin

    6.2%

    6.8%

    6.6%

    7.7%

     

    • Optum second quarter revenues of $62.9 billion grew over $6 billion over the prior year, with growth led by Optum Rx and Optum Health. Operating earnings were $3.9 billion and adjusted operating earnings were $4.3 billion. Adjusted operating earnings exclude costs to support the direct Change Healthcare response efforts. Operating earnings and adjusted operating earnings include $335 million in business disruption impacts at Change Healthcare.
    • Optum Health revenue increased 13% over last year, driven by growth in the number of patients served under value-based care offerings and expansion of the types and level of care provided. Optum Health continued to advance and deepen its clinical support for patients, including those with complex medical needs.
    • Optum Insight operating earnings were $550 million and adjusted operating earnings, which exclude direct response costs, were $940 million. Operating earnings and adjusted operating earnings include the $335 million of business disruption impacts. The revenue backlog grew by over $1 billion over last year, reflecting new health system partnerships.
    • Optum Rx revenue increased 13% in the second quarter due to growth in serving new customers, expanded relationships with existing clients and continued advancement in the comprehensive scope of pharmacy services offered, including specialty and community-based pharmacies. Adjusted scripts grew to nearly 400 million, compared to 380 million last year.

    About UnitedHealth Group

    UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.

    Earnings Conference Call

    As previously announced, UnitedHealth Group will discuss the company's results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company's website (www.unitedhealthgroup.com). Following the call, a webcast replay will be on the Investor Relations page and at https://uhg.com/Replay through July 30, 2024. This earnings release and the Form 8-K dated July 16, 2024, can also be accessed from the Investor Relations page of the company's website.

    Non-GAAP Financial Information

    This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

    Forward-Looking Statements

    The statements, estimates, projections, guidance or outlook contained in this document include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities laws. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ's legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to complete, manage or integrate strategic transactions; risk and uncertainties associated with the pending sale of operations in South America; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events; failure to attract, develop, retain and manage the succession of key employees and executives; our investment portfolio performance; impairment of our goodwill and intangible assets; failure to protect proprietary rights to our databases, software and related products; downgrades in our credit ratings; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, reinvest in our business, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle or continue repurchasing shares of our common stock.

    This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

    UNITEDHEALTH GROUP

    Earnings Release Schedules and Supplementary Information

    Quarter Ended June 30, 2024

    • Condensed Consolidated Statements of Operations
    • Condensed Consolidated Balance Sheets
    • Condensed Consolidated Statements of Cash Flows
    • Revenues by Business - Supplemental Financial Information
    • Earnings by Business - Supplemental Financial Information
    • People Served and Performance Metrics - Supplemental Financial Information
    • Reconciliation of Non-GAAP Financial Measures

    UNITEDHEALTH GROUP

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (in millions, except per share data; unaudited)

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    Revenues

     

     

     

     

     

     

     

     

    Premiums

     

    $76,897

     

    $72,474

     

    $154,885

     

    $145,260

    Products

     

    12,211

     

    10,651

     

    24,120

     

    20,918

    Services

     

    8,750

     

    8,663

     

    17,638

     

    16,743

    Investment and other income

     

    997

     

    1,115

     

    2,008

     

    1,913

    Total revenues

     

    98,855

     

    92,903

     

    198,651

     

    184,834

    Operating costs

     

     

     

     

     

     

     

     

    Medical costs

     

    65,458

     

    60,268

     

    131,193

     

    120,113

    Operating costs

     

    13,162

     

    13,809

     

    27,239

     

    27,434

    Cost of products sold

     

    11,340

     

    9,748

     

    22,396

     

    19,153

    Depreciation and amortization

     

    1,020

     

    1,021

     

    2,017

     

    1,991

    Total operating costs

     

    90,980

     

    84,846

     

    182,845

     

    168,691

    Earnings from operations

     

    7,875

     

    8,057

     

    15,806

     

    16,143

    Interest expense

     

    (985)

     

    (828)

     

    (1,829)

     

    (1,582)

    Loss on sale of subsidiary and subsidiaries held for sale

     

    (1,225)

     

    —

     

    (8,311)

     

    —

    Earnings before income taxes

     

    5,665

     

    7,229

     

    5,666

     

    14,561

    Provision for income taxes

     

    (1,244)

     

    (1,572)

     

    (2,466)

     

    (3,130)

    Net earnings

     

    4,421

     

    5,657

     

    3,200

     

    11,431

    Earnings attributable to noncontrolling interests

     

    (205)

     

    (183)

     

    (393)

     

    (346)

    Net earnings attributable to UnitedHealth Group common shareholders

     

    $4,216

     

    $5,474

     

    $2,807

     

    $11,085

    Diluted earnings per share attributable to UnitedHealth Group common shareholders

     

    $4.54

     

    $5.82

     

    $3.02

     

    $11.77

    Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)

     

    $6.80

     

    $6.14

     

    $13.71

     

    $12.39

    Diluted weighted-average common shares outstanding

     

    928

     

    940

     

    929

     

    942

    (a)

    See page 7 for a reconciliation of non-GAAP measures.

    UNITEDHEALTH GROUP

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (in millions; unaudited)

     

     

     

    June 30,

    2024

     

    December 31,

    2023

    Assets

     

     

     

     

    Cash and short-term investments

     

    $31,323

     

    $29,628

    Accounts receivable, net

     

    23,115

     

    21,276

    Other current assets

     

    37,600

     

    27,533

    Total current assets

     

    92,038

     

    78,437

    Long-term investments

     

    46,113

     

    47,609

    Other long-term assets

     

    147,905

     

    147,674

    Total assets

     

    $286,056

     

    $273,720

    Liabilities, redeemable noncontrolling interests and equity

     

     

     

     

    Medical costs payable

     

    $32,547

     

    $32,395

    Short-term borrowings and current maturities of long-term debt

     

    11,371

     

    4,274

    Other current liabilities

     

    60,752

     

    62,385

    Total current liabilities

     

    104,670

     

    99,054

    Long-term debt, less current maturities

     

    63,727

     

    58,263

    Other long-term liabilities

     

    18,425

     

    17,484

    Redeemable noncontrolling interests

     

    4,558

     

    4,498

    Equity

     

    94,676

     

    94,421

    Total liabilities, redeemable noncontrolling interests and equity

     

    $286,056

     

    $273,720

    UNITEDHEALTH GROUP

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in millions; unaudited)

     

     

     

    Six Months Ended

    June 30,

     

     

    2024

     

    2023

    Operating Activities

     

     

     

     

    Net earnings

     

    $3,200

     

    $11,431

    Noncash items:

     

     

     

     

    Depreciation and amortization

     

    2,017

     

    1,991

    Deferred income taxes and other

     

    101

     

    (573)

    Share-based compensation

     

    594

     

    604

    Loss on sale of subsidiary and subsidiaries held for sale

     

    8,311

     

    —

    Net changes in operating assets and liabilities

     

    (6,333)

     

    13,906

    Cash flows from operating activities

     

    7,890

     

    27,359

    Investing Activities

     

     

     

     

    Purchases of investments, net of sales and maturities

     

    (221)

     

    (1,574)

    Purchases of property, equipment and capitalized software

     

    (1,596)

     

    (1,589)

    Cash paid for acquisitions, net

     

    (3,031)

     

    (8,161)

    Loans to providers - cyberattack

     

    (8,100)

     

    —

    Other, net

     

    (809)

     

    (424)

    Cash flows used for investing activities

     

    (13,757)

     

    (11,748)

    Financing Activities

     

     

     

     

    Common share repurchases

     

    (3,072)

     

    (5,000)

    Dividends paid

     

    (3,664)

     

    (3,284)

    Net change in short-term borrowings and long-term debt

     

    12,790

     

    7,695

    Other, net

     

    981

     

    3,320

    Cash flows from financing activities

     

    7,035

     

    2,731

    Effect of exchange rate changes on cash and cash equivalents

     

    (44)

     

    106

    Increase in cash and cash equivalents, including cash within businesses held for sale

     

    1,124

     

    18,448

    Less: cash within businesses held for sale

     

    (265)

     

    —

    Net increase in cash and cash equivalents

     

    859

     

    18,448

    Cash and cash equivalents, beginning of period

     

    25,427

     

    23,365

    Cash and cash equivalents, end of period

     

    $26,286

     

    $41,813

    UNITEDHEALTH GROUP

    REVENUES BY BUSINESS - SUPPLEMENTAL FINANCIAL INFORMATION

    (in millions; unaudited)

     

     

     

     

     

    Optum

     

    UnitedHealth

    Group

    Consolidated (a)

     

     

    UnitedHealthcare

     

    Optum

    Health

     

    Optum

    Insight

     

    Optum

    Rx

     

    Total

    Optum (a)

     

    Three Months Ended June 30, 2024

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $73,866

     

    $27,050

     

    $4,543

     

    $32,415

     

    $62,879

     

    $98,855

    South American impacts

     

    220

     

    —

     

    —

     

    —

     

    —

     

    220

    Adjusted revenues (b)

     

    $74,086

     

    $27,050

     

    $4,543

     

    $32,415

     

    $62,879

     

    $99,075

    Business disruption impacts - cyberattack (c)

     

    $—

     

    $—

     

    $334

     

    $—

     

    $334

     

    $334

    Three Months Ended June 30, 2023

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $70,231

     

    $23,917

     

    $4,674

     

    $28,646

     

    $56,344

     

    $92,903

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30, 2024

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $149,223

     

    $53,781

     

    $9,045

     

    $63,250

     

    $123,931

     

    $198,651

    South American impacts

     

    220

     

    —

     

    —

     

    —

     

    —

     

    220

    Adjusted revenues (b)

     

    $149,443

     

    $53,781

     

    $9,045

     

    $63,250

     

    $123,931

     

    $198,871

    Business disruption impacts - cyberattack (c)

     

    $—

     

    $—

     

    $613

     

    $—

     

    $613

     

    $613

    Six Months Ended June 30, 2023

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $140,699

     

    $46,921

     

    $9,170

     

    $56,064

     

    $110,403

     

    $184,834

    UnitedHealthcare Revenues

    (in millions; unaudited)

     

     

     

    Employer & Individual (E&I)

     

    Medicare &

    Retirement

     

    Community &

    State

     

    Total

    UnitedHealthcare

     

     

    Domestic

     

    Global

     

    Total E&I

     

     

     

    Three Months Ended June 30, 2024

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $18,646

     

    $591

     

    $19,237

     

    $34,904

     

    $19,725

     

    $73,866

    Three Months Ended June 30, 2023

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $16,759

     

    $2,325

     

    $19,084

     

    $32,440

     

    $18,707

     

    $70,231

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30, 2024

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $36,485

     

    $2,123

     

    $38,608

     

    $70,390

     

    $40,225

     

    $149,223

    Six Months Ended June 30, 2023

     

     

     

     

     

     

     

     

     

     

     

     

    Total revenues

     

    $33,303

     

    $4,488

     

    $37,791

     

    $65,446

     

    $37,462

     

    $140,699

    (a)

    Optum and consolidated revenues for the three months ended June 30, 2024 and 2023 include Optum eliminations of $1,129 and $893; and corporate eliminations of $37,890 and $33,672, respectively. Optum and consolidated revenues for the six months ended June 30, 2024 and 2023 include Optum eliminations of $2,145 and $1,752; and corporate eliminations of $74,503 and $66,268, respectively.

    (b)

    See page 7 for description of non-GAAP measures.

    (c)

    Amounts represent reduced revenues during the business disruption period.

    UNITEDHEALTH GROUP

    EARNINGS BY BUSINESS - SUPPLEMENTAL FINANCIAL INFORMATION

    (in millions, except percentages; unaudited)

     

     

     

     

     

     

    Optum

     

    UnitedHealth

    Group

    Consolidated

     

     

    UnitedHealthcare

     

     

    Optum

    Health

     

    Optum

    Insight

     

    Optum

    Rx

     

    Total

    Optum

     

    Three Months Ended June 30, 2024

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings from operations

     

    $4,004

     

     

    $1,919

     

    $546

     

    $1,406

     

    $3,871

     

    $7,875

    Direct response costs - cyberattack

     

    255

     

    (a)

    22

    (a)

    394

     

    —

     

    416

     

    671

    South American impacts

     

    115

     

     

    —

     

    —

     

    —

     

    —

     

    115

    Adjusted earnings from operations (b)

     

    $4,374

     

     

    $1,941

     

    $940

     

    $1,406

     

    $4,287

     

    $8,661

    Total direct response costs - cyberattack (c)

     

    $255

     

     

    $22

     

    $394

     

    $—

     

    $416

     

    $776

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating margin

     

    5.4 %

     

     

    7.1 %

     

    12.0 %

     

    4.3 %

     

    6.2 %

     

    8.0 %

    Adjusted operating margin (b)

     

    5.9 %

     

     

    7.2 %

     

    20.7 %

     

    4.3 %

     

    6.8 %

     

    8.7 %

    Business disruption impacts - cyberattack (d)

     

    $—

     

     

    $—

     

    $334

     

    $—

     

    $334

     

    $334

    Total cyberattack impacts

     

    $255

     

     

    $22

     

    $728

     

    $—

     

    $750

     

    $1,110

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30, 2023

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings from operations

     

    $4,358

     

     

    $1,525

     

    $968

     

    $1,206

     

    $3,699

     

    $8,057

    Operating margin

     

    6.2 %

     

     

    6.4 %

     

    20.7 %

     

    4.2 %

     

    6.6 %

     

    8.7 %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30, 2024

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings from operations

     

    $8,399

     

     

    $3,818

     

    $1,036

     

    $2,553

     

    $7,407

     

    $15,806

    Direct response costs - cyberattack

     

    485

     

    (a)

    160

    (a)

    619

     

    —

     

    779

     

    1,264

    South American impacts

     

    115

     

     

    —

     

    —

     

    —

     

    —

     

    115

    Adjusted earnings from operations (b)

     

    $8,999

     

     

    $3,978

     

    $1,655

     

    $2,553

     

    $8,186

     

    $17,185

    Total direct response costs - cyberattack (c)

     

    $485

     

     

    $160

     

    $619

     

    $—

     

    $779

     

    $1,369

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating margin

     

    5.6 %

     

     

    7.1 %

     

    11.5 %

     

    4.0 %

     

    6.0 %

     

    8.0 %

    Adjusted operating margin (b)

     

    6.0 %

     

     

    7.4 %

     

    18.3 %

     

    4.0 %

     

    6.6 %

     

    8.6 %

    Business disruption impacts - cyberattack (d)

     

    $—

     

     

    $—

     

    $613

     

    $—

     

    $613

     

    $613

    Total cyberattack impacts

     

    $485

     

     

    $160

     

    $1,232

     

    $—

     

    $1,392

     

    $1,982

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30, 2023

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings from operations

     

    $8,701

     

     

    $3,301

     

    $1,875

     

    $2,266

     

    $7,442

     

    $16,143

    Operating margin

     

    6.2 %

     

     

    7.0 %

     

    20.4 %

     

    4.0 %

     

    6.7 %

     

    8.7 %

    (a)

    Amounts primarily represent incremental medical costs for accommodations to support care providers.

    (b)

    See page 7 for description of non-GAAP measures.

    (c)

    Amounts represent direct response costs incurred within the operating segments and at the parent (e.g., interest expense).

    (d) Amounts represent reduced revenues during the business disruption period. These amounts are not included within the adjustment to earnings from operations.

    UNITEDHEALTH GROUP

    PEOPLE SERVED AND PERFORMANCE METRICS - SUPPLEMENTAL FINANCIAL INFORMATION

    (unaudited)

     

    UnitedHealthcare Customer Profile

    (in thousands)

     

    People Served

     

    June 30, 2024

     

    March 31, 2024

     

    December 31, 2023

     

    June 30, 2023

    Commercial - Domestic:

     

     

     

     

     

     

     

     

    Risk-based

     

    8,735

     

    8,545

     

    8,115

     

    8,035

    Fee-based

     

    20,835

     

    20,870

     

    19,200

     

    19,140

    Total Commercial - Domestic

     

    29,570

     

    29,415

     

    27,315

     

    27,175

    Medicare Advantage

     

    7,770

     

    7,760

     

    7,695

     

    7,590

    Medicaid

     

    7,410

     

    7,680

     

    7,845

     

    8,355

    Medicare Supplement (Standardized)

     

    4,335

     

    4,325

     

    4,355

     

    4,330

    Total Community and Senior

     

    19,515

     

    19,765

     

    19,895

     

    20,275

    Total UnitedHealthcare - Domestic Medical

     

    49,085

     

    49,180

     

    47,210

     

    47,450

    Commercial - Global

     

    1,330

     

    2,295

     

    5,540

     

    5,385

    Total UnitedHealthcare - Medical

     

    50,415

     

    51,475

     

    52,750

     

    52,835

     

     

     

     

     

     

     

     

     

    Supplemental Data

     

     

     

     

     

     

     

     

    Medicare Part D stand-alone

     

    3,065

     

    3,085

     

    3,315

     

    3,355

    Optum Performance Metrics

     

     

     

    June 30, 2024

     

    March 31, 2024

     

    December 31, 2023

     

    June 30, 2023

    Optum Health Consumers Served (in millions)

     

    104

     

    104

     

    103

     

    103

    Optum Insight Contract Backlog (in billions)

     

    $32.6

     

    $32.8

     

    $32.1

     

    $31.4

    Optum Rx Quarterly Adjusted Scripts (in millions)

     

    399

     

    395

     

    400

     

    381

     

    Note: UnitedHealth Group served 149 million unique individuals across all businesses at June 30, 2024.

    UNITEDHEALTH GROUP

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES



    Use of Non-GAAP Financial Measures

    Adjusted net earnings per share, adjusted earnings from operations, adjusted operating margin, adjusted net margin, adjusted revenues and adjusted medical care ratio are non-GAAP financial measures. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. Adjustments made to these measures are as follows:

    Intangible Amortization: Adjusted net earnings per share excludes intangible amortization from the relevant GAAP measure. As amortization fluctuates based on the size and timing of the Company's acquisition activity, management believes this exclusion presents a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company's revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.

    South American Impacts: Adjusted net earnings per share and adjusted net margin excludes the effects of various international transactions, including the loss on sale of our Brazilian operations that was completed on February 6, 2024, the loss on our remaining South American operations being classified as held for sale and certain other non-recurring matters impacting our South American operations. Adjusted earnings from operations, adjusted operating margin, adjusted medical care ratio and adjusted revenues excludes the effects of certain non-recurring matters impacting our South American operations. As these matters are related to the Company's strategy to exit South America, the impact is not representative of the Company's underlying business performance and therefore management believes the exclusion presents a more useful comparison of the Company's underlying business performance and trends from period to period.

    Direct Response Costs - Cyberattack: Adjusted net earnings per share, adjusted earnings from operations, adjusted medical care ratio, adjusted operating margin and adjusted net margin excludes cyberattack direct response costs. Management believes the exclusion of costs incurred to investigate and remediate the attack, other direct and incremental costs incurred as a result of the cyberattack and incremental costs for accommodations to support care providers presents a more useful comparison of the Company's and its reportable segments' underlying business performance and trends from period to period.

    Note: See pages 4 and 5 for reconciliation of GAAP amounts to adjusted revenues, adjusted earnings from operations and adjusted operating margin.

    UNITEDHEALTH GROUP

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

    (in millions, except per share data; unaudited)

    Adjusted Net Earnings Per Share

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

    Projected Year Ended

    December 31,

     

     

    2024

     

    2023

     

    2024

     

    2023

     

    2024

    Net earnings attributable to UnitedHealth Group common shareholders

     

    $4,216

     

    $5,474

     

    $2,807

     

    $11,085

     

    $14,750 - $15,300

    Intangible amortization

     

    417

     

    398

     

    816

     

    786

     

    ~1,600

    Tax effect of intangible amortization

     

    (103)

     

    (100)

     

    (201)

     

    (196)

     

    ~(400)

    South American impacts

     

    1,340

     

    —

     

    8,426

     

    —

     

    ~8,450

    Tax effect of South American impacts

     

    (157)

     

    —

     

    (157)

     

    —

     

    ~(160)

    Direct response costs - cyberattack

     

    776

     

    —

     

    1,369

     

    —

     

    1,600 -1,650

    Tax effect of direct response costs - cyberattack

     

    (182)

     

    —

     

    (323)

     

    —

     

    (375) - (400)

    Adjusted net earnings attributable to UnitedHealth Group common shareholders

     

    $6,307

     

    $5,772

     

    $12,737

     

    $11,675

     

    $25,400 - $26,000

     

     

     

     

     

     

     

     

     

     

     

    Diluted earnings per share

     

    $4.54

     

    $5.82

     

    $3.02

     

    $11.77

     

    $15.95 - $16.40

    Intangible amortization per share

     

    0.45

     

    0.42

     

    0.88

     

    0.83

     

    ~1.75

    Tax effect of intangible amortization per share

     

    (0.11)

     

    (0.10)

     

    (0.22)

     

    (0.21)

     

    ~(0.45)

    South American impacts per share

     

    1.45

     

    —

     

    9.07

     

    —

     

    ~9.10

    Tax effect of South American impacts per share

     

    (0.17)

     

    —

     

    (0.17)

     

    —

     

    ~(0.15)

    Direct response costs - cyberattack per share

     

    0.84

     

    —

     

    1.47

     

    —

     

    1.70 - 1.80

    Tax effects of direct response costs - cyberattack per share

     

    (0.20)

     

    —

     

    (0.34)

     

    —

     

    (0.40) - (0.45)

    Adjusted diluted earnings per share

     

    $6.80

     

    $6.14

     

    $13.71

     

    $12.39

     

    $27.50 - $28.00

     

     

     

     

     

     

     

     

     

     

     

    Additional Information: Total Cyberattack Impacts

     

     

     

     

     

     

     

     

     

     

    Business disruption impacts (a)

     

    $334

     

    $—

     

    $613

     

    $—

     

    $700 - $800

    Tax effect of business disruption impacts (a)

     

    (70)

     

    —

     

    (118)

     

    —

     

    (140) - (160)

    Business disruption impacts, net of tax (a)

     

    $264

     

    $—

     

    $495

     

    $—

     

    $560 - $640

     

     

     

     

     

     

     

     

     

     

     

    Business disruption impacts per share (a)

     

    $0.28

     

    $—

     

    $0.53

     

    $—

     

    $0.60 - $0.70

     

     

     

     

     

     

     

     

     

     

     

    Total cyberattack impacts

     

    $1,110

     

    $—

     

    $1,982

     

    $—

     

    $2,300 - $2,450

    Tax effect of total cyberattack impacts

     

    (252)

     

    —

     

    (441)

     

    —

     

    (515) - (560)

    Total cyberattack impacts, net of tax

     

    $858

     

    $—

     

    $1,541

     

    $—

     

    $1,785 - $1,890

     

     

     

     

     

     

     

     

     

     

     

    Total cyberattack impacts per share

     

    $0.92

     

    $—

     

    $1.66

     

    $—

     

    $1.90 - $2.05

    (a)

    Amounts represent reduced revenues during the business disruption period. These amounts are not included within the adjustment to net earnings.

    Adjusted Net Margin

     

     

     

    Three Months Ended

    June 30, 2024

     

    Six Months Ended

    June 30, 2024

    Consolidated revenue

     

    $98,855

     

    $198,651

    South American impacts

     

    220

     

    220

    Adjusted consolidated revenues

     

    $99,075

     

    $198,871

     

     

     

     

     

    Net earnings attributable to UnitedHealth Group common shareholders

     

    $4,216

     

    $2,807

    South American impacts

     

    1,340

     

    8,426

    Tax effect of South American impacts

     

    (157)

     

    (157)

    Direct response costs - cyberattack

     

    776

     

    1,369

    Tax effect of direct response costs - cyberattack

     

    (182)

     

    (323)

    Adjusted net earnings attributable to UnitedHealth Group common shareholders for South American impacts and direct response costs

     

    $5,993

     

    $12,122

     

     

     

     

     

    Net margin attributable to UnitedHealth Group common shareholders

     

    4.3 %

     

    1.4 %

    Adjusted net margin attributable to UnitedHealth Group common shareholders for South American impacts and direct response costs

     

    6.0 %

     

    6.1 %

    Adjusted Medical Care Ratio

     

     

     

    Projected Year Ended

    December 31, 2024

    Medical care ratio

     

    84.3% +/- 50 bps

    Impact of direct response costs and South American impacts

     

    ~(0.3)%

    Adjusted medical care ratio

     

    84.0% +/- 50 bps

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240716029443/en/

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    1/6/2025$625.00 → $610.00Buy
    Truist
    10/17/2024Buy → Hold
    HSBC Securities
    10/11/2024$675.00Overweight
    KeyBanc Capital Markets
    7/17/2024$555.00 → $615.00Outperform
    RBC Capital Mkts
    7/17/2024$481.00 → $647.00Hold → Buy
    Jefferies
    More analyst ratings

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Flynn Timothy Patrick was granted 180 shares, increasing direct ownership by 2% to 9,123 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:54:06 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Noseworthy John H was granted 180 shares, increasing direct ownership by 3% to 5,763 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:53:55 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Mcnabb Frederick William Iii was granted 183 shares, increasing direct ownership by 1% to 13,656 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:53:44 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Buy to Hold and set a new price target of $490.00

      4/22/25 7:23:13 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by Argus

      Argus downgraded UnitedHealth from Buy to Hold

      4/21/25 8:37:42 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth upgraded by HSBC Securities with a new price target

      HSBC Securities upgraded UnitedHealth from Hold to Buy and set a new price target of $595.00

      1/10/25 9:15:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Flynn Timothy Patrick bought $511,575 worth of shares (1,000 units at $511.57) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      1/22/25 4:05:59 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CareXM adds Home-Based Care Industry Leader, Carla Davis, to its Board of Directors

      CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa

      5/7/25 8:46:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Earnings Release Date

      UnitedHealth Group (NYSE:UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technol

      3/24/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Financials

    Live finance-specific insights

    See more
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh

      3/12/25 4:20:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

      The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on March 18, 2025, to all shareholders of record of UNH common stock as of the close of business March 10, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health b

      2/24/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    See more
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer

      MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. "Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting, and business strategy, including extensive senior leadership experience at multiple Fortune 500 companies, leading large divisions within the healthcare, consumer and retail industries," said Da

      3/14/23 9:00:00 AM ET
      $BBY
      $SNBR
      $TCMD
      $TGT
      Consumer Electronics/Video Chains
      Consumer Discretionary
      Home Furnishings
      Medical/Dental Instruments

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by UnitedHealth Group Incorporated

      SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      5/7/25 10:07:23 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/29/25 4:02:36 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by UnitedHealth Group Incorporated

      DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/21/25 4:06:26 PM ET
      $UNH
      Medical Specialities
      Health Care